Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

NASDAQ:RXRX 4:00:00 PM EDT

6.69

-0.08 (-1.18%)

5:45:39 PM EDT: $6.70 +0.01 (+0.15%)

Market Cap (Intraday)	1.28B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$12.81 Million
Adjusted EPS	-$0.35

See more estimates

10-Day MA	$7.21
50-Day MA	$8.11
200-Day MA	$9.24

See more pivots

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A Stock, NASDAQ:RXRX

41 South Rio Grande Street, Salt Lake City, Utah 84101

United States of America

Phone: +1.385.269.0203

Number of Employees:

http://www.recursion.com

Description

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 5, 2013 and is headquartered in Salt Lake City, UT.